Compare Cassava Sciences Inc (FLNA) vs Ross Stores, Inc. (ROST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs Ross Stores, Inc. — how do they compare? Cassava Sciences Inc trades at $0.82 (market cap $39.40M), while Ross Stores, Inc. trades at $226 (market cap $71.94B). The key difference: Ross Stores, Inc. is far larger — about 1825.9× Cassava Sciences Inc's market cap, and Ross Stores, Inc. pays a 0.79% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Cassava Sciences Inc for 37 Days and Ross Stores, Inc. for 48 Days on average.
| FLNA | ROST | |
|---|---|---|
Market Cap | $39.40M | $71.94B |
Volume | 759,018 | 2,002,519 |
Sector | Health | Consumer Cyclical |
52-Week High | $4.64 | $255.23 |
52-Week Low | $0.68 | $147.71 |
Typical Hold Time | 37 Days | 48 Days |
Enterprise Value | -$43.28M | $72.39B |
Dividend Yield | — | 0.79% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FLNA trades at $0.8157, down 6.77% today, with a bearish technical signal from moving averages. The company shows improving quarterly EPS trends, beating expectations in recent quarters, though it remains unprofitable with negative ROE and ROA. Recent FDA clearance for its epilepsy drug trial provides a positive catalyst. Analyst sentiment is bullish with 67% buy ratings.
The outlook hinges on clinical progress; upside exists if Phase 2a trials succeed, but high cash burn and lack of revenue pose significant risks. Investors should weigh the strong analyst support against the company's financial challenges and binary clinical outcomes.
Ross Stores (ROST) trades at $225.53, up 0.59% today, with a bearish technical signal but strong fundamental performance. The stock shows robust profitability with a net income margin of 10.85% and ROE of 42.63%, supported by consistent earnings beats in recent quarters. Revenue growth trends upward, reaching $21.13B in 2025, while analyst consensus remains bullish with a $274.14 price target. Recent news highlights store expansion and value-focused strategies attracting shoppers amid competitive retail pressures.
The outlook for ROST is positive based on earnings momentum and strategic initiatives, though technical indicators suggest near-term caution. Risks include rising costs and market volatility, but institutional buying and high ROE provide support. The stock offers growth potential if execution on expansion continues, with downside cushioned by strong cash flow and analyst optimism.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About Ross Stores, Inc.
Ross Stores is a leading American off-price apparel and home fashion retailer, operating over 1,920 stores (at the end of fiscal 2021) across the Ross Dress for Less and dd's Discounts banners. Ross offers a variety of name-brand products and targets undercutting conventional retailers' regular prices by 20%-70%. The company uses an opportunistic, flexible merchandising approach
Read more on ROST →
